For the quarter ending 2025-09-30, SGRY had -$46,700K decrease in cash & cash equivalents over the period. $63,800K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Net income | 25,300 | 44,900 | -300 | -46,600 |
| Depreciation and amortization | 39,500 | 40,300 | 36,300 | 33,900 |
| Non-cash lease expense | 9,600 | 9,900 | 9,600 | 9,700 |
| Non-cash interest expense, net | -2,200 | -1,500 | -2,500 | -1,700 |
| Equity-based compensation expense | 2,600 | 6,800 | 7,600 | 6,200 |
| Net loss on disposals, consolidations and deconsolidations | -15,600 | 3,000 | -6,400 | -19,100 |
| Loss on debt extinguishment | -1,300 | 0 | - | 0 |
| Deferred income taxes | 5,100 | -1,500 | -300 | 121,200 |
| Equity in earnings of unconsolidated affiliates, net of distributions received | -800 | 900 | -1,100 | 2,300 |
| Other non-cash income | - | - | - | 0 |
| Accounts receivable | 16,200 | -3,700 | -4,800 | 40,900 |
| Medicare accelerated payments and deferred governmental grants | - | - | - | 0 |
| Other operating assets and liabilities | 2,200 | 20,400 | 61,700 | -9,400 |
| Net cash provided by operating activities | 83,600 | 81,300 | 6,000 | 111,400 |
| Purchases of property and equipment | 19,800 | 23,400 | 22,700 | 22,300 |
| Payments for acquisitions, net of cash acquired | 4,600 | 4,000 | 44,000 | 87,600 |
| Proceeds from disposals of facilities and other assets | 0 | 38,100 | 4,800 | 1,100 |
| Purchases of equity investments | 9,600 | 0 | 3,800 | 0 |
| Proceeds from sales of equity investments | 0 | 0 | - | 600 |
| Other investing activities | 12,200 | 8,600 | 10,700 | 3,500 |
| Net cash used in investing activities | -46,200 | 2,100 | -76,400 | -111,700 |
| Principal payments on long-term debt | 161,000 | 180,100 | 119,300 | 170,500 |
| Borrowings of long-term debt | 127,900 | 168,600 | 213,600 | 265,900 |
| Payments of debt issuance costs | 1,600 | 0 | - | -200 |
| Payment of premium on debt extinguishment | - | - | - | 0 |
| Proceeds from equity offerings | - | - | - | 0 |
| Payments of equity offering costs | - | - | - | 0 |
| Distributions to non-controlling interest holders | 52,500 | 54,000 | 62,300 | 48,100 |
| Proceeds related to ownership transactions with non-controlling interest holders | -600 | 1,400 | 1,700 | 4,000 |
| Other financing activities | 3,700 | 1,500 | -3,500 | -3,500 |
| Net cash (used in) provided by financing activities | -84,100 | -62,600 | 30,200 | 48,000 |
| Net (decrease) increase in cash and cash equivalents | -46,700 | 20,800 | -40,200 | 47,700 |
| Cash and cash equivalents at beginning of period | 250,100 | 229,300 | 269,500 | 221,800 |
| Cash and cash equivalents at end of period | 203,400 | 250,100 | 229,300 | 269,500 |
Surgery Partners, Inc. (SGRY)
Surgery Partners, Inc. (SGRY)